Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STARS: Anastrozole Timing with Radiotherapy in Breast Cancer
NCT00887380Phase 3Unknown
- Sponsor
- Trans-Tasman Radiation Oncology Group
- Start
- Sep 2009
- Primary completion
- Dec 2024
- Modality
- Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 3 trial of anastrozole in breast cancer, sponsored by Trans-Tasman Radiation Oncology Group. Status: unknown.
02
Drugs
anastrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00887380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00887380.